Cargando…

Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson's Disease

Identification of individual risk factors for motor complications in Parkinson's disease (PD) can help to guide personalised medical treatment, particularly since treatment options are still limited. To determine whether common functional gene polymorphisms in the dopamine metabolism predict th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Löhle, Matthias, Mangone, Graziella, Hermann, Wiebke, Hausbrand, Denise, Wolz, Martin, Mende, Julia, Reichmann, Heinz, Hermann, Andreas, Corvol, Jean-Christophe, Storch, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794697/ https://www.ncbi.nlm.nih.gov/pubmed/35096365 http://dx.doi.org/10.1155/2022/5597503

Ejemplares similares

The Pathological Role of Astrocytic MAOB in Parkinsonism Revealed by Genetic Ablation and Over-expression of MAOB
por: An, Heeyoung, et al.
Publicado: (2021)

Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease
por: Nam, Min-Ho, et al.
Publicado: (2022)

Sleep Disturbances and Sleep Disordered Breathing Impair Cognitive Performance in Parkinson’s Disease
por: Hermann, Wiebke, et al.
Publicado: (2020)

Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease
por: Löhle, Matthias, et al.
Publicado: (2011)

Olfactory Training in Patients with Parkinson's Disease
por: Haehner, Antje, et al.
Publicado: (2013)

Effects of safinamide on pain in patients with fluctuating Parkinson's disease
por: Grigoriou, Sotirios, et al.
Publicado: (2021)

The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis
por: Liu, Ying, et al.
Publicado: (2014)

MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation
por: Gonzalez, Irene, et al.
Publicado: (2021)

Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease
por: Falkenburger, Björn, et al.
Publicado: (2022)

Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
por: Babić Leko, Mirjana, et al.
Publicado: (2020)

Impairment in Respiratory Function Contributes to Olfactory Impairment in Amyotrophic Lateral Sclerosis
por: Günther, René, et al.
Publicado: (2018)

X-Vectors: New Quantitative Biomarkers for Early Parkinson's Disease Detection From Speech
por: Jeancolas, Laetitia, et al.
Publicado: (2021)

Clinical Variability of SYNJ1-Associated Early-Onset Parkinsonism
por: Lesage, Suzanne, et al.
Publicado: (2021)

The Association between a MAOB Variable Number Tandem Repeat Polymorphism and Cocaine and Opiate Addictions in Polyconsumers
por: Mateu, César, et al.
Publicado: (2021)

Generation of Astrocyte-Specific MAOB Conditional Knockout Mouse with Minimal Tonic GABA Inhibition
por: Lee, Jung Moo, et al.
Publicado: (2022)

NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
por: Gaurav, Rahul, et al.
Publicado: (2022)

Atrophy of the Vagus Nerve in Parkinson's Disease Revealed by High-Resolution Ultrasonography
por: Walter, Uwe, et al.
Publicado: (2018)

Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease
por: Li, Kai, et al.
Publicado: (2017)

PESISTENT PARKINSONISM AND TARDIVE DYSKINESIA
por: Shaji, K.S., et al.
Publicado: (1995)

Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012)

Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
por: Gaurav, Rahul, et al.
Publicado: (2021)

Inhibition of MAOB Ameliorated High-Fat-Diet-Induced Atherosclerosis by Inhibiting Endothelial Dysfunction and Modulating Gut Microbiota
por: Tian, Zhen, et al.
Publicado: (2023)

Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson’s disease
por: Löhle, Matthias, et al.
Publicado: (2022)

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia
por: Sosero, Yuri L., et al.
Publicado: (2023)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
por: Bektaş, Hesna, et al.
Publicado: (2014)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Surgical Treatment of Dyskinesia in Parkinson’s Disease
por: Munhoz, Renato P., et al.
Publicado: (2014)

Motor-Independent Cognitive Testing in Motor Degenerative Diseases
por: Schmitz-Peiffer, Henning, et al.
Publicado: (2022)

Management of Sleep Disturbances in Parkinson’s Disease
por: Schütz, Lukas, et al.
Publicado: (2022)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Publicado: (2021)

Transdermal rotigotine for the perioperative management of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2010)

Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in MAOB-Knockout Human Hepatoma Cells
por: Tabata, Yuki, et al.
Publicado: (2022)

Relationship between Substantia Nigra Neuromelanin Imaging and Dual Alpha-Synuclein Labeling of Labial Minor in Salivary Glands in Isolated Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Mangone, Graziella, et al.
Publicado: (2022)

Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease
por: Löhle, Matthias, et al.
Publicado: (2023)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
por: Biondetti, Emma, et al.
Publicado: (2021)

Affection of Respiratory Muscles in ALS and SMA
por: Hermann, Wiebke, et al.
Publicado: (2022)

One nerve suffices: A clinically guided nerve ultrasound protocol for the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis (ALS)
por: Loewenbrück, Kai F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p4mvomnsrdidqbp99vf2481br4